A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with wt1 peptides (tlp0-001) in combination with s-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy

HIGHLIGHTS

• who: Masahiro Katsuda from the Second Department of Surgery, Wakayama Medical University, School of Medicine, Kimiidera, Wakayama, Japan have published the research: A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy, in the Journal: (JOURNAL) of March/14,/2017
• what: The aim of this trial is to evaluate the safety and efficacy (as measured by overall survival) of the investigational product by comparing the two groups . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.